Celltrion Launches Autoimmune Disease Biosimilar Avtozma in U.S.
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: The Ministry of Science and ICT announced on Monday that it has requested police intervention to investigate claims that KT Corp. has hindered a
Seoul: Defense Minister Ahn Gyu-back stated on Monday his belief that the U.S. Forces Korea’s (USFK) recent modernization initiatives are primarily focused on enhancing deterrence
Seoul: A Seoul court said Monday it has allowed the broadcast of surveillance camera footage allegedly showing former Prime Minister Han Duck-soo picking up martial
Daegu: The Samsung Lions secured a pivotal victory against the SSG Landers, winning 5-3 on Monday to position themselves one win away from advancing in
Seoul: A Singapore-based investment fund has sold an education-focused commercial building in southern Seoul for around 54 billion won (US$37.8 million), the investment company said